Real-World Use of Sotrovimab for Pre-Emptive Treatment in High-Risk Hospitalized COVID-19 Patients: An Observational Cross-Sectional Study

Data on use of monoclonal antibodies (mAbs) in hospitalized patients are limited. In this cross-sectional study, we evaluated the use of mAbs for early treatment of unvaccinated hospitalized patients with mild-to-moderate COVID-19. All inpatients at our center were screened on 27 October 2021. Prima...

Descripción completa

Detalles Bibliográficos
Autores principales: Ong, Sean W. X., Ren, Dongdong, Lee, Pei Hua, Sutjipto, Stephanie, Dugan, Christopher, Khoo, Bo Yan, Tay, Jun Xin, Vasoo, Shawn, Young, Barnaby E., Lye, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944709/
https://www.ncbi.nlm.nih.gov/pubmed/35326808
http://dx.doi.org/10.3390/antibiotics11030345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944709/
https://www.ncbi.nlm.nih.gov/pubmed/35326808
http://dx.doi.org/10.3390/antibiotics11030345

Ejemplares similares